aluates Reports

$ 0.0

Automative

Global Fibromyalgia Treatment Drug Market Research Report 2025

Published Date: June 2025

Report Code: QYRE-Auto-14A5845

Global Fibromyalgia Treatment Drug Market Insights Forecast to 2028

BUY CHAPTERS

Global Fibromyalgia Treatment Drug Market Research Report 2025

Code: QYRE-Auto-14A5845

Report

June 2025

Pages:91

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Pfizer Inc

Eli Lilly

Actavis Generics

Merck Sharp and Dohme

Innovative Med Concepts

MEDA Co.

Meiji Seika

Switch Biotech

Theravance Inc

Zynerba Pharmaceuticals

Tonix Pharmaceuticals Holding Corp. (TNXP)

Forest Pharmaceuticals, Inc.

Boehringer Ingelheim GmbH

Pierre Fabre Medicament

Daiichi Sankyo

Fibromyalgia Treatment Drug Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Fibromyalgia Treatment Drug Market

The global market for Fibromyalgia Treatment Drug was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Fibromyalgia Treatment Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Fibromyalgia Treatment Drug.

The Fibromyalgia Treatment Drug market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Fibromyalgia Treatment Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Fibromyalgia Treatment Drug companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Fibromyalgia Treatment Drug Market Report

Report Metric	Details
Report Name	Fibromyalgia Treatment Drug Market
CAGR	5%
Segment by Type	Cymbalta (Duloxetine) Savella (Milnacipran) Lyrica (Pregabalin) Pancuronium Others
Segment by Application	Hospital Clinic Household Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Pfizer, Eli Lilly, Actavis Generics, Merck Sharp and Dohme, Daiichi Sankyo, Innovative Med Concepts, Meda, Meiji Seika, Switch Biotech, Theravance, Zynerba Pharmaceuticals, Tonix Pharmaceuticals Holding Corp. (TNXP), Forest Pharmaceuticals, Inc., Boehringer Ingelheim GmbH, Pierre Fabre Medicament
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Fibromyalgia Treatment Drug company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Fibromyalgia Treatment Drug Market report?

Ans: The main players in the Fibromyalgia Treatment Drug Market are Pfizer, Eli Lilly, Actavis Generics, Merck Sharp and Dohme, Daiichi Sankyo, Innovative Med Concepts, Meda, Meiji Seika, Switch Biotech, Theravance, Zynerba Pharmaceuticals, Tonix Pharmaceuticals Holding Corp. (TNXP), Forest Pharmaceuticals, Inc., Boehringer Ingelheim GmbH, Pierre Fabre Medicament

What are the Application segmentation covered in the Fibromyalgia Treatment Drug Market report?

Ans: The Applications covered in the Fibromyalgia Treatment Drug Market report are Hospital, Clinic, Household, Others

What are the Type segmentation covered in the Fibromyalgia Treatment Drug Market report?

Ans: The Types covered in the Fibromyalgia Treatment Drug Market report are Cymbalta (Duloxetine), Savella (Milnacipran), Lyrica (Pregabalin), Pancuronium, Others

Recommended Reports

Pain Management Drugs

Neurodegenerative Drugs

Musculoskeletal Disorders

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Fibromyalgia Treatment Drug Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Cymbalta (Duloxetine)

1.2.3 Savella (Milnacipran)

1.2.4 Lyrica (Pregabalin)

1.2.5 Pancuronium

1.2.6 Others

1.3 Market by Application

1.3.1 Global Fibromyalgia Treatment Drug Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Household

1.3.5 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Fibromyalgia Treatment Drug Market Perspective (2020-2031)

2.2 Global Fibromyalgia Treatment Drug Growth Trends by Region

2.2.1 Global Fibromyalgia Treatment Drug Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Fibromyalgia Treatment Drug Historic Market Size by Region (2020-2025)

2.2.3 Fibromyalgia Treatment Drug Forecasted Market Size by Region (2026-2031)

2.3 Fibromyalgia Treatment Drug Market Dynamics

2.3.1 Fibromyalgia Treatment Drug Industry Trends

2.3.2 Fibromyalgia Treatment Drug Market Drivers

2.3.3 Fibromyalgia Treatment Drug Market Challenges

2.3.4 Fibromyalgia Treatment Drug Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Fibromyalgia Treatment Drug Players by Revenue

3.1.1 Global Top Fibromyalgia Treatment Drug Players by Revenue (2020-2025)

3.1.2 Global Fibromyalgia Treatment Drug Revenue Market Share by Players (2020-2025)

3.2 Global Fibromyalgia Treatment Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Fibromyalgia Treatment Drug Revenue

3.4 Global Fibromyalgia Treatment Drug Market Concentration Ratio

3.4.1 Global Fibromyalgia Treatment Drug Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Fibromyalgia Treatment Drug Revenue in 2024

3.5 Global Key Players of Fibromyalgia Treatment Drug Head office and Area Served

3.6 Global Key Players of Fibromyalgia Treatment Drug, Product and Application

3.7 Global Key Players of Fibromyalgia Treatment Drug, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Fibromyalgia Treatment Drug Breakdown Data by Type

4.1 Global Fibromyalgia Treatment Drug Historic Market Size by Type (2020-2025)

4.2 Global Fibromyalgia Treatment Drug Forecasted Market Size by Type (2026-2031)

5 Fibromyalgia Treatment Drug Breakdown Data by Application

5.1 Global Fibromyalgia Treatment Drug Historic Market Size by Application (2020-2025)

5.2 Global Fibromyalgia Treatment Drug Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Fibromyalgia Treatment Drug Market Size (2020-2031)

6.2 North America Fibromyalgia Treatment Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Fibromyalgia Treatment Drug Market Size by Country (2020-2025)

6.4 North America Fibromyalgia Treatment Drug Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Fibromyalgia Treatment Drug Market Size (2020-2031)

7.2 Europe Fibromyalgia Treatment Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Fibromyalgia Treatment Drug Market Size by Country (2020-2025)

7.4 Europe Fibromyalgia Treatment Drug Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Fibromyalgia Treatment Drug Market Size (2020-2031)

8.2 Asia-Pacific Fibromyalgia Treatment Drug Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Fibromyalgia Treatment Drug Market Size by Region (2020-2025)

8.4 Asia-Pacific Fibromyalgia Treatment Drug Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Fibromyalgia Treatment Drug Market Size (2020-2031)

9.2 Latin America Fibromyalgia Treatment Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Fibromyalgia Treatment Drug Market Size by Country (2020-2025)

9.4 Latin America Fibromyalgia Treatment Drug Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Fibromyalgia Treatment Drug Market Size (2020-2031)

10.2 Middle East & Africa Fibromyalgia Treatment Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Fibromyalgia Treatment Drug Market Size by Country (2020-2025)

10.4 Middle East & Africa Fibromyalgia Treatment Drug Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Pfizer

11.1.1 Pfizer Company Details

11.1.2 Pfizer Business Overview

11.1.3 Pfizer Fibromyalgia Treatment Drug Introduction

11.1.4 Pfizer Revenue in Fibromyalgia Treatment Drug Business (2020-2025)

11.1.5 Pfizer Recent Development

11.2 Eli Lilly

11.2.1 Eli Lilly Company Details

11.2.2 Eli Lilly Business Overview

11.2.3 Eli Lilly Fibromyalgia Treatment Drug Introduction

11.2.4 Eli Lilly Revenue in Fibromyalgia Treatment Drug Business (2020-2025)

11.2.5 Eli Lilly Recent Development

11.3 Actavis Generics

11.3.1 Actavis Generics Company Details

11.3.2 Actavis Generics Business Overview

11.3.3 Actavis Generics Fibromyalgia Treatment Drug Introduction

11.3.4 Actavis Generics Revenue in Fibromyalgia Treatment Drug Business (2020-2025)

11.3.5 Actavis Generics Recent Development

11.4 Merck Sharp and Dohme

11.4.1 Merck Sharp and Dohme Company Details

11.4.2 Merck Sharp and Dohme Business Overview

11.4.3 Merck Sharp and Dohme Fibromyalgia Treatment Drug Introduction

11.4.4 Merck Sharp and Dohme Revenue in Fibromyalgia Treatment Drug Business (2020-2025)

11.4.5 Merck Sharp and Dohme Recent Development

11.5 Daiichi Sankyo

11.5.1 Daiichi Sankyo Company Details

11.5.2 Daiichi Sankyo Business Overview

11.5.3 Daiichi Sankyo Fibromyalgia Treatment Drug Introduction

11.5.4 Daiichi Sankyo Revenue in Fibromyalgia Treatment Drug Business (2020-2025)

11.5.5 Daiichi Sankyo Recent Development

11.6 Innovative Med Concepts

11.6.1 Innovative Med Concepts Company Details

11.6.2 Innovative Med Concepts Business Overview

11.6.3 Innovative Med Concepts Fibromyalgia Treatment Drug Introduction

11.6.4 Innovative Med Concepts Revenue in Fibromyalgia Treatment Drug Business (2020-2025)

11.6.5 Innovative Med Concepts Recent Development

11.7 Meda

11.7.1 Meda Company Details

11.7.2 Meda Business Overview

11.7.3 Meda Fibromyalgia Treatment Drug Introduction

11.7.4 Meda Revenue in Fibromyalgia Treatment Drug Business (2020-2025)

11.7.5 Meda Recent Development

11.8 Meiji Seika

11.8.1 Meiji Seika Company Details

11.8.2 Meiji Seika Business Overview

11.8.3 Meiji Seika Fibromyalgia Treatment Drug Introduction

11.8.4 Meiji Seika Revenue in Fibromyalgia Treatment Drug Business (2020-2025)

11.8.5 Meiji Seika Recent Development

11.9 Switch Biotech

11.9.1 Switch Biotech Company Details

11.9.2 Switch Biotech Business Overview

11.9.3 Switch Biotech Fibromyalgia Treatment Drug Introduction

11.9.4 Switch Biotech Revenue in Fibromyalgia Treatment Drug Business (2020-2025)

11.9.5 Switch Biotech Recent Development

11.10 Theravance

11.10.1 Theravance Company Details

11.10.2 Theravance Business Overview

11.10.3 Theravance Fibromyalgia Treatment Drug Introduction

11.10.4 Theravance Revenue in Fibromyalgia Treatment Drug Business (2020-2025)

11.10.5 Theravance Recent Development

11.11 Zynerba Pharmaceuticals

11.11.1 Zynerba Pharmaceuticals Company Details

11.11.2 Zynerba Pharmaceuticals Business Overview

11.11.3 Zynerba Pharmaceuticals Fibromyalgia Treatment Drug Introduction

11.11.4 Zynerba Pharmaceuticals Revenue in Fibromyalgia Treatment Drug Business (2020-2025)

11.11.5 Zynerba Pharmaceuticals Recent Development

11.12 Tonix Pharmaceuticals Holding Corp. (TNXP)

11.12.1 Tonix Pharmaceuticals Holding Corp. (TNXP) Company Details

11.12.2 Tonix Pharmaceuticals Holding Corp. (TNXP) Business Overview

11.12.3 Tonix Pharmaceuticals Holding Corp. (TNXP) Fibromyalgia Treatment Drug Introduction

11.12.4 Tonix Pharmaceuticals Holding Corp. (TNXP) Revenue in Fibromyalgia Treatment Drug Business (2020-2025)

11.12.5 Tonix Pharmaceuticals Holding Corp. (TNXP) Recent Development

11.13 Daiichi Sankyo

11.13.1 Daiichi Sankyo Company Details

11.13.2 Daiichi Sankyo Business Overview

11.13.3 Daiichi Sankyo Fibromyalgia Treatment Drug Introduction

11.13.4 Daiichi Sankyo Revenue in Fibromyalgia Treatment Drug Business (2020-2025)

11.13.5 Daiichi Sankyo Recent Development

11.14 Forest Pharmaceuticals, Inc.

11.14.1 Forest Pharmaceuticals, Inc. Company Details

11.14.2 Forest Pharmaceuticals, Inc. Business Overview

11.14.3 Forest Pharmaceuticals, Inc. Fibromyalgia Treatment Drug Introduction

11.14.4 Forest Pharmaceuticals, Inc. Revenue in Fibromyalgia Treatment Drug Business (2020-2025)

11.14.5 Forest Pharmaceuticals, Inc. Recent Development

11.15 Boehringer Ingelheim GmbH

11.15.1 Boehringer Ingelheim GmbH Company Details

11.15.2 Boehringer Ingelheim GmbH Business Overview

11.15.3 Boehringer Ingelheim GmbH Fibromyalgia Treatment Drug Introduction

11.15.4 Boehringer Ingelheim GmbH Revenue in Fibromyalgia Treatment Drug Business (2020-2025)

11.15.5 Boehringer Ingelheim GmbH Recent Development

11.16 Pierre Fabre Medicament

11.16.1 Pierre Fabre Medicament Company Details

11.16.2 Pierre Fabre Medicament Business Overview

11.16.3 Pierre Fabre Medicament Fibromyalgia Treatment Drug Introduction

11.16.4 Pierre Fabre Medicament Revenue in Fibromyalgia Treatment Drug Business (2020-2025)

11.16.5 Pierre Fabre Medicament Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Pfizer Inc

Eli Lilly

Actavis Generics

Merck Sharp and Dohme

Innovative Med Concepts

MEDA Co.

Meiji Seika

Switch Biotech

Theravance Inc

Zynerba Pharmaceuticals

Tonix Pharmaceuticals Holding Corp. (TNXP)

Forest Pharmaceuticals, Inc.

Boehringer Ingelheim GmbH

Pierre Fabre Medicament

Daiichi Sankyo

List of Tables

Table 1. Global Fibromyalgia Treatment Drug Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Cymbalta (Duloxetine)

Table 3. Key Players of Savella (Milnacipran)

Table 4. Key Players of Lyrica (Pregabalin)

Table 5. Key Players of Pancuronium

Table 6. Key Players of Others

Table 7. Global Fibromyalgia Treatment Drug Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 8. Global Fibromyalgia Treatment Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 9. Global Fibromyalgia Treatment Drug Market Size by Region (2020-2025) & (US$ Million)

Table 10. Global Fibromyalgia Treatment Drug Market Share by Region (2020-2025)

Table 11. Global Fibromyalgia Treatment Drug Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 12. Global Fibromyalgia Treatment Drug Market Share by Region (2026-2031)

Table 13. Fibromyalgia Treatment Drug Market Trends

Table 14. Fibromyalgia Treatment Drug Market Drivers

Table 15. Fibromyalgia Treatment Drug Market Challenges

Table 16. Fibromyalgia Treatment Drug Market Restraints

Table 17. Global Fibromyalgia Treatment Drug Revenue by Players (2020-2025) & (US$ Million)

Table 18. Global Fibromyalgia Treatment Drug Market Share by Players (2020-2025)

Table 19. Global Top Fibromyalgia Treatment Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Fibromyalgia Treatment Drug as of 2024)

Table 20. Ranking of Global Top Fibromyalgia Treatment Drug Companies by Revenue (US$ Million) in 2024

Table 21. Global 5 Largest Players Market Share by Fibromyalgia Treatment Drug Revenue (CR5 and HHI) & (2020-2025)

Table 22. Global Key Players of Fibromyalgia Treatment Drug, Headquarters and Area Served

Table 23. Global Key Players of Fibromyalgia Treatment Drug, Product and Application

Table 24. Global Key Players of Fibromyalgia Treatment Drug, Date of Enter into This Industry

Table 25. Mergers & Acquisitions, Expansion Plans

Table 26. Global Fibromyalgia Treatment Drug Market Size by Type (2020-2025) & (US$ Million)

Table 27. Global Fibromyalgia Treatment Drug Revenue Market Share by Type (2020-2025)

Table 28. Global Fibromyalgia Treatment Drug Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 29. Global Fibromyalgia Treatment Drug Revenue Market Share by Type (2026-2031)

Table 30. Global Fibromyalgia Treatment Drug Market Size by Application (2020-2025) & (US$ Million)

Table 31. Global Fibromyalgia Treatment Drug Revenue Market Share by Application (2020-2025)

Table 32. Global Fibromyalgia Treatment Drug Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 33. Global Fibromyalgia Treatment Drug Revenue Market Share by Application (2026-2031)

Table 34. North America Fibromyalgia Treatment Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. North America Fibromyalgia Treatment Drug Market Size by Country (2020-2025) & (US$ Million)

Table 36. North America Fibromyalgia Treatment Drug Market Size by Country (2026-2031) & (US$ Million)

Table 37. Europe Fibromyalgia Treatment Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 38. Europe Fibromyalgia Treatment Drug Market Size by Country (2020-2025) & (US$ Million)

Table 39. Europe Fibromyalgia Treatment Drug Market Size by Country (2026-2031) & (US$ Million)

Table 40. Asia-Pacific Fibromyalgia Treatment Drug Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 41. Asia-Pacific Fibromyalgia Treatment Drug Market Size by Region (2020-2025) & (US$ Million)

Table 42. Asia-Pacific Fibromyalgia Treatment Drug Market Size by Region (2026-2031) & (US$ Million)

Table 43. Latin America Fibromyalgia Treatment Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Latin America Fibromyalgia Treatment Drug Market Size by Country (2020-2025) & (US$ Million)

Table 45. Latin America Fibromyalgia Treatment Drug Market Size by Country (2026-2031) & (US$ Million)

Table 46. Middle East & Africa Fibromyalgia Treatment Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 47. Middle East & Africa Fibromyalgia Treatment Drug Market Size by Country (2020-2025) & (US$ Million)

Table 48. Middle East & Africa Fibromyalgia Treatment Drug Market Size by Country (2026-2031) & (US$ Million)

Table 49. Pfizer Company Details

Table 50. Pfizer Business Overview

Table 51. Pfizer Fibromyalgia Treatment Drug Product

Table 52. Pfizer Revenue in Fibromyalgia Treatment Drug Business (2020-2025) & (US$ Million)

Table 53. Pfizer Recent Development

Table 54. Eli Lilly Company Details

Table 55. Eli Lilly Business Overview

Table 56. Eli Lilly Fibromyalgia Treatment Drug Product

Table 57. Eli Lilly Revenue in Fibromyalgia Treatment Drug Business (2020-2025) & (US$ Million)

Table 58. Eli Lilly Recent Development

Table 59. Actavis Generics Company Details

Table 60. Actavis Generics Business Overview

Table 61. Actavis Generics Fibromyalgia Treatment Drug Product

Table 62. Actavis Generics Revenue in Fibromyalgia Treatment Drug Business (2020-2025) & (US$ Million)

Table 63. Actavis Generics Recent Development

Table 64. Merck Sharp and Dohme Company Details

Table 65. Merck Sharp and Dohme Business Overview

Table 66. Merck Sharp and Dohme Fibromyalgia Treatment Drug Product

Table 67. Merck Sharp and Dohme Revenue in Fibromyalgia Treatment Drug Business (2020-2025) & (US$ Million)

Table 68. Merck Sharp and Dohme Recent Development

Table 69. Daiichi Sankyo Company Details

Table 70. Daiichi Sankyo Business Overview

Table 71. Daiichi Sankyo Fibromyalgia Treatment Drug Product

Table 72. Daiichi Sankyo Revenue in Fibromyalgia Treatment Drug Business (2020-2025) & (US$ Million)

Table 73. Daiichi Sankyo Recent Development

Table 74. Innovative Med Concepts Company Details

Table 75. Innovative Med Concepts Business Overview

Table 76. Innovative Med Concepts Fibromyalgia Treatment Drug Product

Table 77. Innovative Med Concepts Revenue in Fibromyalgia Treatment Drug Business (2020-2025) & (US$ Million)

Table 78. Innovative Med Concepts Recent Development

Table 79. Meda Company Details

Table 80. Meda Business Overview

Table 81. Meda Fibromyalgia Treatment Drug Product

Table 82. Meda Revenue in Fibromyalgia Treatment Drug Business (2020-2025) & (US$ Million)

Table 83. Meda Recent Development

Table 84. Meiji Seika Company Details

Table 85. Meiji Seika Business Overview

Table 86. Meiji Seika Fibromyalgia Treatment Drug Product

Table 87. Meiji Seika Revenue in Fibromyalgia Treatment Drug Business (2020-2025) & (US$ Million)

Table 88. Meiji Seika Recent Development

Table 89. Switch Biotech Company Details

Table 90. Switch Biotech Business Overview

Table 91. Switch Biotech Fibromyalgia Treatment Drug Product

Table 92. Switch Biotech Revenue in Fibromyalgia Treatment Drug Business (2020-2025) & (US$ Million)

Table 93. Switch Biotech Recent Development

Table 94. Theravance Company Details

Table 95. Theravance Business Overview

Table 96. Theravance Fibromyalgia Treatment Drug Product

Table 97. Theravance Revenue in Fibromyalgia Treatment Drug Business (2020-2025) & (US$ Million)

Table 98. Theravance Recent Development

Table 99. Zynerba Pharmaceuticals Company Details

Table 100. Zynerba Pharmaceuticals Business Overview

Table 101. Zynerba Pharmaceuticals Fibromyalgia Treatment Drug Product

Table 102. Zynerba Pharmaceuticals Revenue in Fibromyalgia Treatment Drug Business (2020-2025) & (US$ Million)

Table 103. Zynerba Pharmaceuticals Recent Development

Table 104. Tonix Pharmaceuticals Holding Corp. (TNXP) Company Details

Table 105. Tonix Pharmaceuticals Holding Corp. (TNXP) Business Overview

Table 106. Tonix Pharmaceuticals Holding Corp. (TNXP) Fibromyalgia Treatment Drug Product

Table 107. Tonix Pharmaceuticals Holding Corp. (TNXP) Revenue in Fibromyalgia Treatment Drug Business (2020-2025) & (US$ Million)

Table 108. Tonix Pharmaceuticals Holding Corp. (TNXP) Recent Development

Table 109. Daiichi Sankyo Company Details

Table 110. Daiichi Sankyo Business Overview

Table 111. Daiichi Sankyo Fibromyalgia Treatment Drug Product

Table 112. Daiichi Sankyo Revenue in Fibromyalgia Treatment Drug Business (2020-2025) & (US$ Million)

Table 113. Daiichi Sankyo Recent Development

Table 114. Forest Pharmaceuticals, Inc. Company Details

Table 115. Forest Pharmaceuticals, Inc. Business Overview

Table 116. Forest Pharmaceuticals, Inc. Fibromyalgia Treatment Drug Product

Table 117. Forest Pharmaceuticals, Inc. Revenue in Fibromyalgia Treatment Drug Business (2020-2025) & (US$ Million)

Table 118. Forest Pharmaceuticals, Inc. Recent Development

Table 119. Boehringer Ingelheim GmbH Company Details

Table 120. Boehringer Ingelheim GmbH Business Overview

Table 121. Boehringer Ingelheim GmbH Fibromyalgia Treatment Drug Product

Table 122. Boehringer Ingelheim GmbH Revenue in Fibromyalgia Treatment Drug Business (2020-2025) & (US$ Million)

Table 123. Boehringer Ingelheim GmbH Recent Development

Table 124. Pierre Fabre Medicament Company Details

Table 125. Pierre Fabre Medicament Business Overview

Table 126. Pierre Fabre Medicament Fibromyalgia Treatment Drug Product

Table 127. Pierre Fabre Medicament Revenue in Fibromyalgia Treatment Drug Business (2020-2025) & (US$ Million)

Table 128. Pierre Fabre Medicament Recent Development

Table 129. Research Programs/Design for This Report

Table 130. Key Data Information from Secondary Sources

Table 131. Key Data Information from Primary Sources

Table 132. Authors List of This Report

List of Figures

Figure 1. Fibromyalgia Treatment Drug Picture

Figure 2. Global Fibromyalgia Treatment Drug Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Fibromyalgia Treatment Drug Market Share by Type: 2024 VS 2031

Figure 4. Cymbalta (Duloxetine) Features

Figure 5. Savella (Milnacipran) Features

Figure 6. Lyrica (Pregabalin) Features

Figure 7. Pancuronium Features

Figure 8. Others Features

Figure 9. Global Fibromyalgia Treatment Drug Market Size by Application (2020-2031) & (US$ Million)

Figure 10. Global Fibromyalgia Treatment Drug Market Share by Application: 2024 VS 2031

Figure 11. Hospital Case Studies

Figure 12. Clinic Case Studies

Figure 13. Household Case Studies

Figure 14. Others Case Studies

Figure 15. Fibromyalgia Treatment Drug Report Years Considered

Figure 16. Global Fibromyalgia Treatment Drug Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 17. Global Fibromyalgia Treatment Drug Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 18. Global Fibromyalgia Treatment Drug Market Share by Region: 2024 VS 2031

Figure 19. Global Fibromyalgia Treatment Drug Market Share by Players in 2024

Figure 20. Global Top Fibromyalgia Treatment Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Fibromyalgia Treatment Drug as of 2024)

Figure 21. The Top 10 and 5 Players Market Share by Fibromyalgia Treatment Drug Revenue in 2024

Figure 22. North America Fibromyalgia Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. North America Fibromyalgia Treatment Drug Market Share by Country (2020-2031)

Figure 24. United States Fibromyalgia Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Canada Fibromyalgia Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. Europe Fibromyalgia Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Europe Fibromyalgia Treatment Drug Market Share by Country (2020-2031)

Figure 28. Germany Fibromyalgia Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. France Fibromyalgia Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. U.K. Fibromyalgia Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Italy Fibromyalgia Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Russia Fibromyalgia Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Nordic Countries Fibromyalgia Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Asia-Pacific Fibromyalgia Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Asia-Pacific Fibromyalgia Treatment Drug Market Share by Region (2020-2031)

Figure 36. China Fibromyalgia Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Japan Fibromyalgia Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. South Korea Fibromyalgia Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Southeast Asia Fibromyalgia Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. India Fibromyalgia Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Australia Fibromyalgia Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Latin America Fibromyalgia Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Latin America Fibromyalgia Treatment Drug Market Share by Country (2020-2031)

Figure 44. Mexico Fibromyalgia Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Brazil Fibromyalgia Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Middle East & Africa Fibromyalgia Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Middle East & Africa Fibromyalgia Treatment Drug Market Share by Country (2020-2031)

Figure 48. Turkey Fibromyalgia Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. Saudi Arabia Fibromyalgia Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 50. UAE Fibromyalgia Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 51. Pfizer Revenue Growth Rate in Fibromyalgia Treatment Drug Business (2020-2025)

Figure 52. Eli Lilly Revenue Growth Rate in Fibromyalgia Treatment Drug Business (2020-2025)

Figure 53. Actavis Generics Revenue Growth Rate in Fibromyalgia Treatment Drug Business (2020-2025)

Figure 54. Merck Sharp and Dohme Revenue Growth Rate in Fibromyalgia Treatment Drug Business (2020-2025)

Figure 55. Daiichi Sankyo Revenue Growth Rate in Fibromyalgia Treatment Drug Business (2020-2025)

Figure 56. Innovative Med Concepts Revenue Growth Rate in Fibromyalgia Treatment Drug Business (2020-2025)

Figure 57. Meda Revenue Growth Rate in Fibromyalgia Treatment Drug Business (2020-2025)

Figure 58. Meiji Seika Revenue Growth Rate in Fibromyalgia Treatment Drug Business (2020-2025)

Figure 59. Switch Biotech Revenue Growth Rate in Fibromyalgia Treatment Drug Business (2020-2025)

Figure 60. Theravance Revenue Growth Rate in Fibromyalgia Treatment Drug Business (2020-2025)

Figure 61. Zynerba Pharmaceuticals Revenue Growth Rate in Fibromyalgia Treatment Drug Business (2020-2025)

Figure 62. Tonix Pharmaceuticals Holding Corp. (TNXP) Revenue Growth Rate in Fibromyalgia Treatment Drug Business (2020-2025)

Figure 63. Daiichi Sankyo Revenue Growth Rate in Fibromyalgia Treatment Drug Business (2020-2025)

Figure 64. Forest Pharmaceuticals, Inc. Revenue Growth Rate in Fibromyalgia Treatment Drug Business (2020-2025)

Figure 65. Boehringer Ingelheim GmbH Revenue Growth Rate in Fibromyalgia Treatment Drug Business (2020-2025)

Figure 66. Pierre Fabre Medicament Revenue Growth Rate in Fibromyalgia Treatment Drug Business (2020-2025)

Figure 67. Bottom-up and Top-down Approaches for This Report

Figure 68. Data Triangulation

Figure 69. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Fibromyalgia Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Medications for Fibromyalgia Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Fibromyalgia Antidepressant Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Chronic Pain Treatment Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Arthritis Pain Treatment Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Rheumatic Disorders Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Pain Therapy Device Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Idiopathic Pulmonary Fibrosis Treatment Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Back and Spine Pain Treatment Solutions Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Fibrate Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Neck Pain Treatment Solutions Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Chronic Pain Management Drugs Market Research Report 2025

Fibrocystic Breasts Diagnostics and Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Nerve Pain Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Fibrinolytic Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Anti Migraine Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Rheumatology Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Prescription Pain Relievers Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Pain Relief Medications Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions